The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell-like properties through modulation of self-renewal signaling
- PMID: 31308814
- PMCID: PMC6606826
- DOI: 10.1016/j.jgr.2018.05.004
The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell-like properties through modulation of self-renewal signaling
Abstract
Background: The ginsenoside Rg3, one of active components of red ginseng, has chemopreventive and anticancer potential. Cancer stem cells retain self-renewal properties which account for cancer recurrence and resistance to anticancer therapy. In our present study, we investigated whether the standardized Korean Red Ginseng extract (RGE) and Rg3 could modulate the manifestation of breast cancer stem cell-like features through regulation of self-renewal activity.
Methods: The effects of RGE and Rg3 on the proportion of CD44high/CD24low cells, as representative characteristics of stem-like breast cancer cells, were determined by flow cytometry. The mammosphere formation assay was performed to assess self-renewal capacities of breast cancer cells. Aldehyde dehydrogenase activity of MCF-7 mammospheres was measured by the ALDEFLUOR assay. The expression levels of Sox-2, Bmi-1, and P-Akt and the nuclear localization of hypoxia inducible factor-1α in MCF-7 mammospheres were verified by immunoblot analysis.
Results: Both RGE and Rg3 decreased the viability of breast cancer cells and significantly reduced the populations of CD44high/CD24low in MDA-MB-231 cells. RGE and Rg3 treatment attenuated the expression of Sox-2 and Bmi-1 by inhibiting the nuclear localization of hypoxia inducible factor-1α in MCF-7 mammospheres. Suppression of the manifestation of breast cancer stem cell-like properties by Rg3 was mediated through the blockade of Akt-mediated self-renewal signaling.
Conclusion: This study suggests that Rg3 has a therapeutic potential targeting breast cancer stem cells.
Keywords: Breast cancer stem cells; Ginseng; Ginsenoside Rg3; Red ginseng extract; Self-renewal.
Figures






Similar articles
-
Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation.J Ginseng Res. 2017 Oct;41(4):548-555. doi: 10.1016/j.jgr.2016.11.003. Epub 2017 Jan 13. J Ginseng Res. 2017. PMID: 29021703 Free PMC article.
-
Rg3-enriched red ginseng extract promotes lung cancer cell apoptosis and mitophagy by ROS production.J Ginseng Res. 2022 Jan;46(1):138-146. doi: 10.1016/j.jgr.2021.05.005. Epub 2021 May 19. J Ginseng Res. 2022. PMID: 35058730 Free PMC article.
-
Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway.Toxicol Appl Pharmacol. 2025 Jan;494:117158. doi: 10.1016/j.taap.2024.117158. Epub 2024 Nov 17. Toxicol Appl Pharmacol. 2025. PMID: 39561883
-
Effect of Korean Red Ginseng on metabolic syndrome.J Ginseng Res. 2021 May;45(3):380-389. doi: 10.1016/j.jgr.2020.11.002. Epub 2020 Nov 12. J Ginseng Res. 2021. PMID: 34025131 Free PMC article. Review.
-
Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds.J Korean Med Sci. 2001 Dec;16 Suppl(Suppl):S6-18. doi: 10.3346/jkms.2001.16.S.S6. J Korean Med Sci. 2001. PMID: 11748383 Free PMC article. Review.
Cited by
-
Cancer Stem Cell Characteristics by Network Analysis of Transcriptome Data Stemness Indices in Breast Carcinoma.J Oncol. 2020 Oct 6;2020:8841622. doi: 10.1155/2020/8841622. eCollection 2020. J Oncol. 2020. PMID: 33082784 Free PMC article.
-
20(S)-Protopanaxdiol Suppresses the Abnormal Granule-Monocyte Differentiation of Hematopoietic Stem Cells in 4T1 Breast Cancer-Bearing Mouse.Evid Based Complement Alternat Med. 2020 Jan 3;2020:8747023. doi: 10.1155/2020/8747023. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32015754 Free PMC article.
-
Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer.Aging (Albany NY). 2021 Jun 10;13(13):17177-17189. doi: 10.18632/aging.203131. Epub 2021 Jun 10. Aging (Albany NY). 2021. PMID: 34111025 Free PMC article.
-
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer.Front Pharmacol. 2021 Dec 3;12:731741. doi: 10.3389/fphar.2021.731741. eCollection 2021. Front Pharmacol. 2021. PMID: 34925002 Free PMC article. Review.
-
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer.Chin Med. 2023 Sep 25;18(1):125. doi: 10.1186/s13020-023-00822-9. Chin Med. 2023. PMID: 37749560 Free PMC article. Review.
References
-
- Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. - PubMed
-
- Ailles L.E., Weissman I.L. Cancer stem cells in solid tumors. Curr Opin Biotechnol. 2007;18:460–466. - PubMed
-
- Bjerkvig R., Tysnes B.B., Aboody K.S., Najbauer J., Terzis A.J. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer. 2005;5:899–904. - PubMed
-
- Klonisch T., Wiechec E., Hombach-Klonisch S., Ande S.R., Wesselborg S., Schulze-Osthoff K., Los M. Cancer stem cell markers in common cancers-therapeutic implications. Trends in Mol Med. 2008;14:450–460. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous